
The South Korean government has launched a preemptive review of drug and medical device supply conditions as the prolonged war in the Middle East heightens global supply chain instability. While domestic supply remains stable, the move aims to proactively examine the healthcare supply chain management system in anticipation of extended geopolitical risks.
The Ministry of Health and Welfare (MOHW) held a meeting of health and medical-related agencies on Middle East war response in Seoul on the 31st. Officials discussed the supply and demand status of pharmaceuticals and medical products along with future response measures. Representatives from the Korean Medical Association, the Korean Hospital Association and other medical groups joined pharmaceutical and medical device production and distribution organizations to share on-the-ground conditions.
Vice Minister of Health and Welfare Lee Hyung-hoon said in his opening remarks, "As the Middle East war crisis drags on, public concerns are growing." He added, "We need to conduct preemptive reviews to ensure no disruptions arise in the supply of pharmaceuticals and medical products used at medical facilities."
"The government has activated a government-wide emergency economic monitoring system to respond to energy supply difficulties and financial market volatility," Lee said. "The health and medical sector is no exception, and we will proactively manage the supply chain."
At the meeting, the government intensively discussed the current supply status of pharmaceuticals and medical products, on-the-ground difficulties and concerns, and response directions for potential supply instability. In particular, officials reviewed plans to strengthen supply monitoring systems and establish communication channels between the medical community and industry to prepare for possible supply disruptions.
The MOHW assessed that domestic supply of pharmaceuticals and medical products has remained broadly stable so far. However, the ministry noted that the situation could change if geopolitical uncertainty persists. Accordingly, it plans to go beyond simple reviews and establish a preemptive response system based on field-level input.
"We will thoroughly listen to opinions from the field and respond swiftly to ensure no disruptions occur in the supply of pharmaceuticals and medical products used in daily life and at medical facilities," Vice Minister Lee said. "If the medical community and the government cooperate, we can protect public health even amid the repercussions of war."
The government plans to continue reviewing its supply chain management system through consultations with related agencies and will prepare additional response measures as needed.
